Grail Inc
NASDAQ:GRAL

Watchlist Manager
Grail Inc Logo
Grail Inc
NASDAQ:GRAL
Watchlist
Price: 95.06 USD 0.14% Market Closed
Market Cap: 3.7B USD

Operating Margin
Grail Inc

-385.5%
Current
-873%
Average
-3.9%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-385.5%
=
Operating Profit
-546.7m
/
Revenue
141.8m

Operating Margin Across Competitors

Country Company Market Cap Operating
Margin
US
Grail Inc
NASDAQ:GRAL
3.4B USD
-385%
FR
Pharnext SCA
OTC:PNEXF
6T USD
-17 527%
US
Abbvie Inc
NYSE:ABBV
395.4B USD
33%
US
Amgen Inc
NASDAQ:AMGN
171.5B USD
34%
US
Gilead Sciences Inc
NASDAQ:GILD
153.5B USD
39%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
112.9B USD
39%
US
Epizyme Inc
F:EPE
94.1B EUR
-370%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
77.6B USD
28%
AU
CSL Ltd
ASX:CSL
86.6B AUD
26%
NL
argenx SE
XBRU:ARGX
46.7B EUR
22%
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
53.6B USD
8%
No Stocks Found

Grail Inc
Glance View

Market Cap
3.4B USD
Industry
Biotechnology

Grail Inc is a US-based company operating in Biotechnology industry. The company is headquartered in Menlo Park, California and currently employs 1,370 full-time employees. The company went IPO on 2024-06-12. GRAIL, Inc., formerly GRAIL, LLC, is a healthcare company, which is engaged in saving lives and shifting the paradigm in early cancer detection. The company is focused on alleviating the global burden of cancer by using next-generation sequencing, population-scale clinical studies, and machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. Its targeted methylation-based platform can support the continuum of care for screening and precision oncology, including multi-cancer early detection in symptomatic patients, risk stratification, minimal residual disease detection, biomarker subtyping, treatment and recurrence monitoring. Its products include Galleri and Beyond. The Galleri test is a commercially available screening test for early detection of multiple types of cancer, which is termed multi-cancer early detection (MCED). Galleri screening test results can help guide next steps for a diagnosis of cancer by healthcare providers.

GRAL Intrinsic Value
HIDDEN
Show
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-385.5%
=
Operating Profit
-546.7m
/
Revenue
141.8m
What is the Operating Margin of Grail Inc?

Based on Grail Inc's most recent financial statements, the company has Operating Margin of -385.5%.

Back to Top